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Dendritic epidermal T c ells (DETC), which are skin-
specific members of the tissue- resident yo T -cell 
family, are characterized by their potential to kill 
selected tumor targets by a non-major histocompat-
ibility complex (MHC)-restricted mechanism. We 
have recently identified a new receptor molecule, 
2B4, that appears t o be associated with non-MHC-
restricted recognition of tumor targets by natural 
killer cells. The purpose of this study was to deter-
mine whether DETC express 2B4 molecules, and, if 
so, to assess their functional roles in DETC-mediated 
killing o f tumor targets. Short-term DETC lines as 
well as DETC freshly procured from skin expressed 
surface 2B4, as detected with a specific monoclonal 
antibody. Removal of interleukin (IL)-2 from DETC 
cultures caused substantial reduction in 2B4 expres-
T wo leukocyte popul ations res ide norm ally in m o use epidermis : (1) dendritic epiderma l T cells (DETC), w hich arc a member of the epithelial tissue- type y8 T-ccll family (reviewed in [1 ,2 '1), and (2) Langerhans cells, wh ich arc profess ional antigen-presenting cells 
of the dcndt·itic ce ll family (reviewed in (3]). It is impo rta11t that 
DETC ex hibi t a potent capacity to kill se lected tumor targets [4 ,5] , 
and La ngcrhans ce ll s are ca pable of initiating an a{3 T -cell-
dependent protective immunity against tumo r-assoc iated antigens 
[6]. T here fo re, it appears that skin is protected aga inst tumor 
developmen t by these two le ukocyte popu lation s. 
DETC freshl y isola ted fro m m o use skin do not exhibit significant 
ki lling ac tivi ty, but they acq uire th is activity sho rtly afte r culture in 
the presence of conca navalin A (Con A) and re lative ly low 
concen trations (5-1 0 U/ml) of in te rl euk.in (fL)-2 14,7] . O nce 
activated. those short-term DETC lin es demonstrate potent capac-
iti es to kill a w ide varie ty of tumor ta rgets, incl uding Y AC-1 
lympho ma [4J, ultravio let-induced fibrosarcoma 1_8] , ma li gnant 
melanomas L 7 J, and transformed keratinocytes [7] . W c have re-
ported previously the fo ll owing observations: 1) DETC-mediated 
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sion levels as well as a reduction in cytotoxic capacity 
against Y AC-1 targets in a standard 51 Cr-release as-
say. Conversely, exposure to IL-2, but not to IL-7, 
elevated both 2B4 expression and cytotoxicity. To 
assess the functional roles played by surface 2B4, we 
pretreated DETC lines with anti-2B4 antibody and 
then tested for their killing potential. Anti-2B4, but 
not the control antibody, augm.ented their capacity 
to lyse YAC-1 targets (51 Cr-release assays) and to 
disrupt the monolayers of Pam-212-transformed ke-
ratinocytes (visual assessment). Thus, we conclude 
that DETC express, in an IL-2-dependent manner, 
2B4 molecules, which may play a unique role in the 
killing of skin-derived tumors.] ltwest Demwtol 105: 
592-596, 1995 
cytotoxicity occurs rega rdless of majo r hi stocompatibility complex 
(MHC) combinations; 2) it ca nnot be blocked by antibodies against 
CD3 o r T-cel l receptor (TCR); and 3) ki lling appears to be directed 
aga inst transformed cell s (i.e ., normal cells are not susceptible) 
1_ 5,7]. T hese characteristics suggest that DETC recognize tumor 
targets through a non-MHC-restricted mechanism [9 , 1 0]. 
We ha ve described previously a new molecule , termed 2B4. 
w hi ch is a 66-kD glycoprotein expressed by virtually all natural 
ki ll er (NK) and T cell s that mediate non- MHC -rcs tricted killing 
Ill , 12]. When mouse spleen cell s were fra ctionated into 2B4 + and 
2B4 - po pulatio ns, cytotox icity aga in st YAC-1 was detected exclu-
sive ly within the 2B4 + fract io n. Moreover, a CD3 + / NK1.1 +I 
284+ T-cell line is ca pable of killing B-ce ll hybrido mas producing 
an ti-28 4 monoclo nal antibody (MoAb) but not hybridomas pro-
du cin g anti-NKl.l MoAb, suggestin g that inte raction of 2B4 with 
its ligand (i.e . , surface anti-2B4 antibod ies in th is case) mediates 
cytotox ic recognition [1 2]. Most recently, we have cloned eDNA 
for 2B4, which contains a sing le open reading fi·ame of 11 94 
nu cleotidcs encoding a polypeptide of 398 amino acids. 2B4 shows 
signifi cant (46'Yc, to 47%) hom o logy to rat and mouse C D 48, human 
LFA-3, and mouse CD4, and the inclusio n of th e consensus moti f 
of an immunoglo bulin (I g) C-2 domain has suggested further that 
2B4 is a member of the Ig gene superfamily [13]. In the present 
study, we sought to determine whether cytotoxic .DETC express 
284, and, if so, to assess the ro le played by 2B4 in DETC-mediated 
ki llin g of tumor targets. 
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Table I. Summary of 2B4 Expression and Function on DETC Lines 
DET C Lines 
7-1 7 
Fea tures 608 609 6 10 6 16 625 705 707 825 90S 9 14 (AKR.) 
Vy3 expression" 645 1' 245 587 988 101 2 485 822 1050 976 11 47 78 
Cytotoxicity'· NT'' 38' 28 23 21 22 19 22 NT NT NT 
2B4 expression 
Sur face proteir/ 207-' 14 6 85 ISS 98 36 117 165 243 231 0 
mRNA" NT + + + NT + + NT NT NT + 
F u nctio nal activi tyi NT + + + + + + NT NT NT NT 
" DETC lines were cxalllincd for surf:tcc expression of V y3 TC R by single staining with the anti- V-y3 MoAb . 
b Spe ci fi c flu o rescence intensity: the m enu in tensit-y \Vith anti- Vy3 minus th e m ean inten sity willt co ntro l Ig:G . 
r DETC lines were cx a1nincd fO r their capacity to lyse YA C -1 t ;1rg c r in a stand ard 6-h 5 1C r-rc lcasc assny . 
d No r tested . 
r: Pe r ce n t specific lysis at the cflCcw r:targcc ratio o f 20 : I o r 25 :'1. 
f DETC lines were l!xamin cd fo r surf:H;c ex pressio n of 2 134 by sing le staining wi th ;m ri-2 134 M oA b . 
J! Spe ci fic Auorcsccncc iH t:cnsity: the m ean intensity w ith anti-2 134 miJius the lncan inl cnsity with cont ro l IgG. 
11 DETC lines we re examined for 2B4 mfl NA expression b y N o rth ern bl otting . 
i DETC lines we re cx ami_n cd co dete rmin e w hc tiH.: r :nu:i-2.13 4 MoA b enh anced their ki ll ing capacity ag:ains t Y AC - 1 t:u gc ts. 
MATEIUALS AND METH O DS R E SULT S 
' C ells Epidermal cells were prepared from the skin of female B 1 O.D2 mice 
(1 0 -1 6 weeks old ; J ackson Laboratories, Bar Harbor, ME) as described 
pre vio usly [1.4]. Briefl y, epidennal cell s isolated by two sequential trypsin 
rreaon ents we re enri ched for DET C by centrifugation over 1-listopaque; the 
' cells r ecovered fi·01n the intcrf:tce , usuall y containing 10% to 20% D.ETC , 
wei:e used in this stud y. To establi sh short-term D ET C lines . interface 
epidennal ce ll s were cul rured in comple te IU>MI in the presence of2 J.Lg/ ml 
Con A and 5 ng/ml human recombinant IL-2 (rlL-2) ["1 5]. The cells were 
' resrin1ulated every "14 d with 1 J.Lg/ml Con A and fed with fresh medium 
containing 5 ng/ ml riL-2 every 3 or 4 d . These lines were expanded in bulk 
cul tu res and used for the experiments G to 12 weeks after es tablishment, at 
which time they were sti.l.l "'polyclonal " in nature. W e :tl so used the long-
tem l DET C line, 7-17, which was established front fluorescence-acti vated 
cell so rte r (FACS) purified D ETC in AKL<. mice [5,16]. YAC-1 and Pam 
212 k e ra tinocytc li nes w ere used as ta rgets and w ere rnaintaincd as 
desc ribed previo usly [7]. 
Cytokines Murine r!L-6, I L-7, IL-8, IL-1 0, granulocyte--macrophage 
" colon y- stimulating f.1 ctor, transforming growth f.1 ctor-!3·1, and macrophage 
( inflammato ry protei.n- la were purchased fi·om R &D Syste ms (Minneapolis , 
) MN) ; IL-2 and interferon- y were from Gibco (Grand Island, NY) ; 'md 
l"L- la and IL-4 were i]·om Genzyme (Cambridge, MA) . Murine r!L-1 2 was 
' a kind gi ft from Dr. Sypek, Genetics Institute (Cambridge , MA). 
Rilling Assays T he capacity of D ET C lines to kill YA C-1 targets was 
examined in a 5 1C r-rclease assay, as before [5 ,7] . The abili ty of the cell s to 
disrupt the monolayers of Pam 212 kcratinocyte targets was tested by a 
1 visual assay, as described prev iously [7]. Briefl y. Pam 212 cells were first 
cultured o n 24-well plates to form monolayers, and e ffecto r D.ETC were 
then plated on to p o f these mono la ye rs. After 24 h of incuba tion. the well s 
were washed ex tensively to remove nonadherent D ETC and dis lodged 
targe t cell s and fmally stained with l 1Y,, crystal violet in me thanol. Areas 
without dark sta in were comidercd to be foci of target cell di sruption. 
Microscopic fea tures of such foci have been described elsewhere [7 J. 
FACS Analysis Surface expressio n o f 2134 by D ET C lines was examined 
1 by staining with fluoresce in isothiocyanate (FJTC)-conjugated anti-2B4 
MoA b (Pharmingen, San Diego, CA) at 4 ~tg/ ml. O ther fea tures o f this 
an tibod y arc described elsewhere [11 , "12 J. FITC- conjugated mo use lgG 2 b 
(Phanningen) was used as a class-matched lgG con trol. DETC lines were 
also s tained with hamster Mo.A b against Vy3 T C R. (Pitarmingcn) followed 
by FTTC-conjugat<:d rabbit anti-hamster lgG Qackson, W es t Grove, PA) , in 
( which hamster lgG served as a control. To examine 2B4 expression by 
DETC in freshl y iso la ted epiderma l cell s, cell s were double stained with 
FJTC- conjugatcd anti-2B4 and phycoe rythrin-conjugated anti-Thy-1.2 
MoAb (Becton-Dickinson, Mountain View, C A) . 
Northern Blotting 2B4 mRNA expression was assessed by Northern 
blotti11g as described previously (17,1 8], in which p2B4.8 ["13] was used as 
a prob e. 
2B4 Expression by DETC Because the anti-2B 4 MoAb recog-
nizes 2B4 molecules that are e xpressed in sp ecifi c strains of mice, 
including B1 0 [11 ,12], w e first examine d sh o rt-te rm D ETC lines 
n e w ly establishe d fi·om B 1 0 m ice . A s sumnu1rized in Table I , each 
of 10 consecuti ve ce ll lines e:\.-pre ssed V -y3 TCR , a D ET C - specifi c 
marke r [1], veri fying the ir lin eage. E ach lin e a lso expressed signif-
icant amounts of 2B4, as d e te cted by the anti-2B 4 MoA b . B y 
contrast, the A KR-derive d long- te rm DETC lin e, 7-17, expressed 
V-y3 T C R , but anti-2B4 MoAb fail ed to d e tect 2B4 expression . 
B ecause 2B4 is n o t o rdinaril y d e tec table in AKR. mice with o ur 
anti-2B4 MoAb , thi s "negative control ' ' docume nts th e fin e sp ec-
ificity o f 2B4 staining. In Northern blotting , w e d e tec te d con stitu-
tive mR.NA expression for 2B 4 by e ach of the five tested Bl O-
de rived D ETC lines and by the 7-17line . Each BlO-derived D ETC 
line also exhibited sig nifi.cant kilLing of YAC-1 targe ts in 5 1C r-
releasc assays (Table I). T hus, w e conclude that virtually all the 
sh o rt-term D ETC lin es establi sh ed in this study exhibi ted a cyto-
toxi c capacity and, at the sam e time, expresse d the 2B 4 m o lecul e . 
A n intrig uing asp ect of DET~-mediated tumo r killing is that 
cells freshly isolate d fi:o m skin fitil to kill tumor targe ts, and acquire 
tlu s capac ity only a fte r se ve ra l days in culture [4 , 7] . T h e re fore, it 
was of particular inte res t to exan"iine wheth e r freshly isolate d 
D ET C also e xpress ce ll surface 2B4 . T hy-1 + epide rmal cell s freshly 
isolate d from BlO mice (i .e ., DETC ) showed re la tive ly homoge-
ne ous expression of 2B4 (Fig 1) . Nonspecific bindi11g o f contro l 
lg G to T h y-1 - ce lls most like ly reflects Fe bindin g to Langerhan s 
cells. It is important tha t 2B4 e xpression le vels were conside rably 
lowe r in fresh D ETC thm1 in short-te rm D ETC lines, suggesting 
that 2B 4 e xpression is up-regulated b y a fac tor(s) present in the 
cul ture m edium . 
IL-2 Up-Regulates 2B4 Expression and Cytotoxic Capaci-
ties T o es ta b lish D ETC lines , e pide rmal ce lls arc stimula te d with 
C o n A and exposed continuo u sly to re latively small amounts (2 .5-5 
ng/ ml , or 5-10 U / ml) of riL-2. There fore . on e candidate fa c to r 
responsible to r 2B 4 up-regulation w as exoge nous lL-2. To te st this 
po ssibility, w e culture d the 707 D ET C .line for 2 d in the presen ce 
or absence o f r!L-2 and then e xamin ed for 2B4 e xpress ion. l.n the 
continuous presen ce of 5 n g/ml IL-2 , a concentratio n o rdin;u·ily 
present in cu lture m e dia , the cells expressed 2B 4 a t ordin ary leve ls 
(Fig 2A). On the othe r hand, re mov al o f lL-2 from the culture 
medium caused a sig nifi cant reduc tio n in 2B 4 express ion. In 
marke d contrast , IL-7 , w hich al so promotes the g rowth o f DETC 
(19] , fa iled to induce any d etectable changes in 2B 4 expre ssio n at 
any concentration tested . ln a diffe re nt se t of experim en ts, w e 
594 SCHUI-I MACI-I ERS ET AL 
o bserved th at added Con A (1 Mglml) did not m o dulate 2D4 
express io n by the sa m e DETC lin e (data not shown). These resul ts 
suggest that IL-2, w hi ch w as added as a growth f.octo r, up- regul ated 
surface express ion of 2B4 in cul ture. 
Cells prccul turcd fo r 2 d in the presence or absen ce o f IL-2 o r 
IL- 7 w ere a lso exa mined fo r the ir capacity to lyse YA C -1 targe ts. 
W e o bserved a p ositive re lati on between the level of2B 4 expres-
sion and cytotox icity; LL-2 up-regulated both acti vities in a dose-
dependen t m ann er, and IL-7 fa il ed to m odul ate e ithe r activity (Fig 
2A ) . Cells cul tured witho ut any added cytokin es o r with JL- 7 alon e 
main ta ined viabilities above so•x., suggestin g that the obser ved 
d iffe rences in cytotoxicity d id not simply re fl ec t chan ges in cell 
viabil ity. O n the other hand , diffe rent concen tration s of IL- 2 were 
requ ired for 2B4 up- regul ation and fo r killing activ ities; 5 ng/ml 
was suffic ien t to main ta in m aximal express io n o f 2B 4, w hereas this 
concen tration w as not sufficien t to ind uce m axim al cy to toxic ity. 
M o reover, the m agni tu de o f IL- 2-dependen t up-regulation was 
modest fo r 2B4 express ion (tw o fo ld) compared with that fo r 
cytotoxicity (almost tenfo ld) . T hese o bserva tio ns suggest that 
up-regula ted 2B4 expression is not the only m echani sm by which 
lL-2 augm en ts cytotoxic poten tial. 
In a re lated study, th e DETC line w as cultured with each of ·12 
difl:e rent cytokincs and th en tested fo r k illin g capacity (Fig 2B) . 
Again, ce lls exposed to IL- 2 dem onstrated an e leva ted cyto toxicity 
compared w ith cells m ain ta ined in m edi a alone. By contrast, o the r 
cytokin es, including IL- 7 and IL-1 2, failed to m odula te the cyto-
lytic poten tia l of DETC. T hese resul ts illustrate the IL- 2 specific ity 
of this regu latio n . 
Functional Roles Played by 2B4 in D ETC-Media ted Killing 
In the next se t of ex pe.-imen ts, we sought to characte ri ze the ro le 
played by 2B 4 during DETC-mediated killin g. W e ha ve sh own 
previo usly that o ur an ti-2B4 M o Ab augm ents, rath e r th an blocks, 
the capac ity of natural kille r cells to k ill Y AC -1 targets [1 2]. T hi s 
augm entation. is no t attribu ta bl e to Fe binding of lgG to natural 
kille r ce ll s, beca use F(ab) 2 ' o f anti -2B4 M oA b also sho w ed sig nif-
ica n t acti vity. We h ave in terpre ted this to suggest tha t o ur M o Ab 
recognizes a signalin g do m ain , rathe r than a ligand-bindin g do-
main , of th e 2ll4 m o lecul e . As noted in F ig 3 , DETC pretreated 
w ith an ti-2B4 MoA b lysed th e Y AC-1 ta rgets mo re e ffec ti vely than 
d id cell s pretreated w ith an isotype-m atched contro l IgG 2 ". B ase-
lin e cytotox ic ca pac ity in the absence of e ithe r lgG was virtu ally 
indistinguishab le fro m th at seen in th e presence o f contro l IgG2 " 
(data not shown) . T his influ ence of anti-2B4 was o bserved con sis-
ten tly w ith each of six tested D ETC lin es (Table I) . W e thus 
conclude tha t li gation of2B4 m olecules on the DETC surface leads 
to an au gm ented abili ty to lyse Y AC-1 targe ts. 
Fresh EC 
608 DETC 
Figure 1. 2B4 expression by freshly isolated DETC. ln te rf:1ce epider-
mal cell s {EC) iso lated from 131 0 mice were double stained with FITC-
conjuga ted anri-2 13 4 MoAb or control lgG 2., and with phycoerythrin-
conjugated anti- T hy-1 .2 MoAb. T he 131 0-derived short-te rm DETC line, 
608, was stain <>d in pa ra lld . Ri_~llt , histograms with an ti-2 13 4 (shaded) or 
control lgG (ope11) within the T hy-1 ' populations. 
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Figure 2. Cytokinc-dependen t regula tion of surface 2B4 expres-
sion and cytotoxic capaci ty . A , the 707 DETC line was cul tured for 2 d 
in the presence of the indi c~1tcd concentrati o ns of IL-2 o r IL-7 . Ce ll s were 
then examined fo r 2134 expression (fij i ) , their capacity to lys<> YAC-1 targets 
at the d Fector:targ<>t ratio of20: I ("'irlrlle). and cdl viabili ty by trypan blue 
exclusion (r(~ht) . Data shown arc re la tive express ion levels of 2D4 (median 
Auor<>sce ncc in tensity IF L]) , pcrc<>nt specific lysis (mean :!:: SD, n = 3). and 
percent viabili ty. 13 , tlw 825 DETC line was cul tured for 2 din the presence 
of each of th<> indicated cytokines. Numbers in parentheses indicate thl' 
cy tokinc concentrations, in U/ ml for intcrferon-y (lFN y) or in ng/rnl for 
the otlwrs. Cells were then exarnined fo r their capacity to lys<> Y AC- 1 
targe ts. Data shown nrc the mean :!:: SD (n = 3) of the p<>rC<>nt specific lysis 
at the efFector/target ratio of 58:1 in a G-h assay. GM-CS F, gr;mulocytc--
m 3cro phagc colo ny-stin1ulati ng f..1cto r; TGF {31. transfo rming growth £:1cror 
/3 1; M ll'- '1 u , macrophage inflammato ry prote in- ! u. 
W e have reported previously that DETC lines are able to lyse the 
Pam 212 transform ed keratinocytc lin e in con ventional 51 Cr-
re lease assays [7] . Moreover , DETC lin es, when plated on Pam 2L 
m ono la ye rs, caused marked des tructio n o f the m onolayers. T he 
latter assay w as m o re sensitive and appeared to mimic i11 uirto 
circum stan ces , with e ffector ce ll s binding to th e m ass of tumor ce lls 
J7]. T herefo re, w e sought to de te rmine wheth er anti-2B4 MoAb 
au gm ents the abili ty of D ET C lin es to damage confluent monolay-
ers of Pam 212 keratinocytes. As no ted in Fig 4, DETC pretrea ted 
wi th anti-2B4 Mo Ab produced m o re profound des truction of Pam 
212 m ono laye rs than did th e sam e effector cells pretreated with an 
isotype-matched control lgG . With 1 X 10'' e ffector cells, for 
instance , only a partial disruption w as seen wi th contro l lgG , 
w hereas alm ost comple te des tru ctio n was achieved with anti-2B.J 
M oAb. In con tro l experiments, anti-2B4 Mo Ab did not bind to the 
Pam 212 cell surface as m easured by FACS an alysis, no r did it cause 
destruc tion of Pam 212 m onolaye rs in the absence of DETC (data 
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Figure 3. Anti-2B4 augments DETC-mcdiatcd killing of Y AC-1 
targets. DETC lines were prcincubatcd to r 30 min at 4°C with 7.5 J..tg/ ml 
of anti-2B4 MoAb or control lgG2,. After ex tensive washing, the cells were 
tested for their capacity to lyse YAC-1 targets at the indicated effector/ 
target ratios. Data shown are the rncan ± SD (n = 3) of the percent specifi c 
lysis in a 6-h assay. 
not shown) . Thus, w e conclude that DETC acquire, upon liga tion 
of surface 2B4, an in creased abili ty to disrupt the m ono layer 
, structure of transfo rm ed kcratinocytes. 
DISCUSSION 
In the present study, we have observed that 2B4, a new member of 
' the Ig gen e superfa mi ly, is expressed by sho rt- te rm DETC lines as 
well as in DETC fi·eshly procured fi·o m skin . 2B4 expression levels 
appeared to corre late with cytotoxic capacities: 1) Freshl y isolated 
DETC expressed low amounts of 2B4 and fai led to kill Y AC-1 
[4, 7]; 2) IL- 2 augmented both 2B4 expression and ki ll ing activi ties, 
w h e reas lL-7 affec ted neither 2B4 expression nor cytotoxic ity; and 
3) 2B4 express io n was not de tec ted in othe r epide rmal ceUs (i.e., 
keratinocytes o r .La ngerhans cells) , which do not o rdinarily ex hibit 
cytotoxicity. W e ha ve reported previously that non-MJ-IC-re-
stricted cytotoxicity in spleen cell popu lations is also confined 
within 2B4 + cells [1 2] . It is noteworthy that 2B4 is not expressed by 
aU the killer leukocytes; for instance, 2B4 w as presen t in an a(3 
T - cellline, CTLL-2, w hich ex hibi ts non- MHC-res tricted ki ll ing of 
f tumors, bu t it w as not de tected in an allospecific cos+ cytotoxic 
T - cell line [1 2]. T hese results support our working hypothes is that 
2B4 expression delineates leukocyte populations (e. g., natural killer 
cells and DETC ) that m ediate non-MH C-restricted killing of 
tumor cells. 
O n e characteristic feature of DETC is their capacity to kill a 
variety of targe ts, includin g skin-deri ved tumors [4,5 ,7,8]. DETC 
are also characterized by the mon oclonal nature in their TCR 
configuration ; virtually e ve ry DETC in skin expresses the sam e 
TCR (V)'3/V 01) without a junctiona l activi ty p]. T he lack of 
diversity, t hen, suggests that D ETC can recognize through the ir 
TCR o nJ y one or a limited set of antigens, which would be 
inducibl e in neighborin g cell s by "stressfu l stimu li" in the environ-
m e nt [20]. In this regard, Ha vran et nl [21] have reported that 
DETC ac tiv;ttion (as m easured by !L- 2 secretion) can be tri ggered 
by an as yet und efined molecule (s) expressed on Pam 212 kcrati-
nocytes but n ot on untransform ed, no rmal kcratinocytes , <tnd that 
this recogni tion is blocked completely by anti-V)'3 MoAb. O n the 
oth e r hand , w e have reported that the same DETC Lin e is capable 
of killing Pam 212 keratinocytes but not no rmal keratinocytcs; tlli s 
interaction w as not b locked by anti-V)'3 M oAb [7]. T h erefore , it 
appears that " cytotoxic' ' recogni tion and "antige nic ' ' recogni tion 
of th e sam e tum o r ta rgets occur through distinc t m echanism s. The 
present study has prov ided a new insigh t into this dogm a: DETC, 
like natural k ill er ce lls that lack the TCR /CD3 complex, may usc 
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the 2B4 o r re lated m olecules for ' 'cytotoxic" recogr1ition of Pam 
212 k c ratin ocytes . 
W e h ave shown previously th at a CD3 + /2B4 " / NK1.1 .,. T-cell 
Line th at exhibi ts non-MH C -rcsb·icted kilLing lysed B-cell hybrido-
m as producing anti-2B4 MoA b, but not hybridomas produ cin g 
an ti-NK1 .1 MoAb [1 2]. T hese resul ts sugges t that th e interaction of 
2B4 with its liga nd, anti-2B4 MoAb in this case, m ay m ediate 
cytotoxi c recognition. O n the oth et· hand , ligation of surfa ce 2B4 
w ith anti-2B4 MoAb resul ted in augm entation , rathe r than block-
ing , of cyto tox ic capacity. We in te rpret this to sugges t that our 
MoAb recognizes an cpitope in the signaling domain , rathe r than 
the ligand- binding domain , of the 2B4 m o lecu le. In fa c t, an ti-2B4 
MoAb did trigger the secretion of serine es terase by n a tural ki lle r 
ce lls [1 2]. More recentl y, we h ave o bserved tha t DETC lines 
..q 
~ a:l 







707 DETC ~ + I "--"' "--"' 
0 
0 25 I 06 . X 
Pan1 212 
Figure 4. Anti-2B4 augments DETC-mcdiated killing of trans-
formed kcrat inocytc<. T he 707 DETC line was firs t incubated for 30 min 
at 4°C with 7.5 J..tg/ ml of anti-2B4 MoAb or controll gG 2h. Ce lls were then 
plated. in the indicated cell numbers, onto co'nflucnt Pam 212 monolayers 
prepared on 24-well plates . After 24 h incubation, the we ll s were washed 
extensively and then stained wi th l "A, crys tal violet in methanol. In tact 
kcrati no cytc rno no laycrs arc dense ly swincd. w hereas lucent areas re present 
foci of target cell disrup tion . 
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secrete in te rfe ron--y and IL- 2 in respon se to ligation of surface 2B 4 
wi th immo bilized an tibodies [22]. T hu s, it appears that surface 2B4 
m olecul es not only facilitate the recogni tion o f targets, bu t al so 
h·ansduce, upon liga tion , signals that lead to augm ented cytotox -
icity. Apparen tly, seve ral issues rem ain to be addressed , including : 
(1) the m ech anism s by which liga tion o f surface 2B4 augm ents 
killing function (e.g. , e laboration of soluble facto rs) ; (2) the iden tity 
of n atural ligand(s) of 2B4, which are m ost like ly expressed on th e 
tumor ce ll surface; and (3) a 2B4 equi va lent in human s. 
lt is known that selected cytokin es, e.g., IL-2, IL-7 , and fL-12 , 
trigger the genera tion o f non-MH C -restri c ted killing ac tivities in 
leukocytes (9,23-25]. With respect to the m echani sm, IL-2 and 
IL-7 hav e been shown to up-regulate th e genera ti on of cytotoxic 
substances (e.g., perforin) in kille r leukocytes (24]. W e observed in 
th is study that fL-2 , but not o the r cyto kines (e.g., IL-7 and LL-12) , 
enhan ced the cytotoxic po ten tial and also e levated the surf., ce 
express ion of 2B4 . T hese results m ay suggest an alte rnative m ech-
anism fo r cy tokjn e-dependent regul atio n o f killing po ten tials; i. e ., 
IL - 2 ma y enhance cytotoxic potential by up-regul ating the surface 
expression of target recogni tion m olecules (e .g .. 2B4). 
T his st11dy 111ns s11pportcd IJ)' Nntio 11al IJlslilllfes <!I 1-/en /rh grn11fs R O"l AR35068, 
RO I AR40042, R O'I ll R 4 1150, n111/ "/PJO A R 4"/940, th e Dcmurtology Fo ll/1-
dnt iou, a rescmrlt gr(/flf ji·om J\tfnry Ka y Cosmt!l ics, fu r., the Lester I. Conrad 
Fo11ndntio/l , Tlcc Pcn-y R . n/l d Nn /IC)' Lee Bass Rcstnrclc Fnnd, n111/ th e 0 C'IIlschc 
Forsell 1111gs,gem ei /Jscll aft . 
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